Scientific Publications by FDA Staff

Food Chem Toxicol 2017 Nov;109(Pt 1):253-63

Effects of residual levels of tetracycline on the barrier functions of human intestinal epithelial cells.

Gokulan K, Cerniglia CE, Thomas C, Pineiro SA, Khare S

Tetracyclines are frequently used in food-producing animals to treat, control, and prevent microbial diseases. Concerns are raised regarding the effects of residual levels of tetracycline, which may be present in the food supply, for emergence of drug-resistance and transfer of antibiotic-resistance gene in intestinal microflora. In contrast, no information is available regarding the possible effects of residual tetracycline on the gastrointestinal epithelial layer barrier-disruption. This study investigates the outcome of tetracycline treatment on intestinal epithelial cells integrity. Intestinal epithelial cells (T84) were treated at concentrations of 0.015, 0.15, 1.5, 15 and 150 mug/ml for 48 h in an in vitro cell culture model. The permeability study revealed that 15 and 150 mug/ml of tetracycline causes barrier disruption. Whereas the altered mRNA expression of notch-3, notch-4, claudin-2, claudin-8, claudin-10, claudin-15, gap junction alpha 8 and delta 2 and integrin, alpha 3 and alpha L, which are cell-integrity-related genes starts at 1.5 mug/ml tetracycline after 48 h treatment. Translocation of GFP-labeled bacteria from apical to basal comportment provides proof of concept to intestinal barrier disruption. This study is the first to evaluate whether residual concentrations of tetracycline impact epithelial cell integrity.